Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction
Experimental Hematology · 2026-08 · 160 · 105459
DOI: 10.1016/j.exphem.2026.105459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2026-08. Verfasst von Sumit Jamwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yale University School of Medicine, New Haven, CT. Electronic address: sumit.jamwal@yale.edu. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Adaptive Immunity, Inflammation, Hemolysis. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Sickle cell disease (SCD) is increasingly acknowledged not only as a hemoglobinopathy, but also as a disorder of immune remodeling driven by persistent hemolysis and chronic inflammation. In this perspective review, we propose a mechanistic scaffold in which hemolysis-associated damage-associated molecular patterns (DAMPs) initiate sustained innate immune activation that reshapes bone marrow niche i.e., alter hematopoietic stem and progenitor cell fate, alters lymphopoiesis, and progressively remodels adaptive immunity. We discuss emerging evidence linking chronic inflammatory signaling to T-cell activation, altered helper T-cell polarization, impaired germinal center dynamics, and depletion of memory B-cell compartments. We further highlight age-dependent immune remodeling across pediatric and adult SCD populations and discuss how these alterations may contribute to impaired vaccine response, increased susceptibility to infection, and transfusion-related alloimmunization. By integrating insights from hematopoiesis, inflammation, and adaptive immunity, this perspective reframes SCD-associated hemolysis and immune dysfunction as a central component of disease pathophysiology and identifies potential directions for future immunomodulatory and vaccine-focused therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Yale University School of Medicine, New Haven, CT. Electronic address: sumit.jamwal@yale.edu.
- Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
- Department of Pediatrics, Yale University School of Medicine, New Haven, CT.
- Department of Pediatrics, Yale University School of Medicine, New Haven, CT; Yale Center for Infection and Immunity, Yale University, New Haven, CT; Epidemiology of Microbial Diseases, Yale School of Public Health, New…
Förderung
- NIAID NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Jamwal, S., Mohanty, S., Calhoun, C., Krishnamurti, L., Montgomery, R. R., Shaw, A. C., & Yildirim, I. (2026). Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction. Experimental Hematology, 160, 105459. https://doi.org/10.1016/j.exphem.2026.105459
Vancouver
Jamwal S, Mohanty S, Calhoun C, Krishnamurti L, Montgomery RR, Shaw AC, et al. Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction. Experimental Hematology. 2026;160:105459. doi:10.1016/j.exphem.2026.105459
BibTeX
@article{Jamwal2026,
author = {Jamwal, Sumit and Mohanty, Subhasis and Calhoun, Cecelia and Krishnamurti, Lakshmanan and Montgomery, Ruth R and Shaw, Albert C and Yildirim, Inci},
title = {Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction},
journal = {Experimental Hematology},
year = {2026},
volume = {160},
pages = {105459},
doi = {10.1016/j.exphem.2026.105459}
}
EUVIMED